BIOSIG TECHNOLOGIES, INC. Common Stock (par value $0.001 per share) At-The- Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • September 15th, 2023 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
Contract Type FiledSeptember 15th, 2023 Company Industry JurisdictionBioSig Technologies, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows: